Related Experiment Video
Updated: Jun 16, 2025

Visualization of DNA Replication in the Vertebrate Model System DT40 using the DNA Fiber Technique
Published on: October 27, 2011
DNA polymerase beta expression in head & neck cancer modulates the poly(ADP-ribose)-mediated replication checkpoint
Md Maruf Khan1, Wynand P Roos2, Charlotte R Pearson2
1Department of Pharmacology & Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School & Legorreta Cancer Center, Brown University, Providence, RI 02912, USA.
In head and neck cancer, inhibiting PARG triggers cell death, but Polβ overexpression causes resistance. Combining PARG and ATR/CHK1 inhibitors overcomes this resistance, offering a new HNSCC treatment strategy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Head and Neck Squamous Cell Carcinoma (HNSCC) presents significant treatment challenges due to limited efficacy and severe side effects of current therapies.
- DNA polymerase beta (Polβ) plays a critical role in DNA replication stress and cellular responses to DNA damage.
- Poly(ADP-ribose) glycohydrolase (PARG) regulates poly(ADP-ribose) (PAR) levels, influencing DNA damage response pathways.
Purpose of the Study:
- To investigate the role of Polβ in HNSCC response to PARG inhibitors.
- To explore therapeutic strategies for overcoming Polβ-mediated resistance to PARG inhibitors in HNSCC.
- To evaluate the efficacy of combining PARG inhibitors with ATR/CHK1 inhibitors.
Main Methods:
- Assessed cellular responses to PARG inhibition in HNSCC cells with varying Polβ levels.
- Investigated replication stress, cell cycle arrest, and apoptosis induction.
- Performed in vitro experiments combining PARG inhibitors with ATR/CHK1 inhibitors.
Main Results:
- PARG inhibition in HNSCC cells induced replication stress and apoptosis, but Polβ overexpression mitigated this response.
- HNSCC cells overexpressing Polβ exhibited resistance to PARG inhibitor treatment.
- Combination therapy of PARG and ATR/CHK1 inhibitors demonstrated synergistic effects, overcoming Polβ-mediated resistance.
Conclusions:
- Polβ levels critically influence HNSCC sensitivity to PARG inhibitors.
- Targeting Polβ-mediated resistance through combination therapy with PARG and ATR/CHK1 inhibitors is a promising strategy for HNSCC.
- This approach offers a potential new therapeutic paradigm for improving HNSCC treatment outcomes.
More Related Videos
06:44Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
08:53Strand-Specific Analysis of Proteins at Replicating DNA Strands by Enrichment and Sequencing of Protein-Associated Nascent DNA Method
Published on: May 2, 2025
Related Concept Videos
Proofreading
Errors During Replication are Corrected by the DNA Polymerase...
DNA Damage can Stall the Cell Cycle
The DNA Replication Fork
Restarting Stalled Replication Forks
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
DNA Helicases